D-Index & Metrics Best Publications

Kristiina Aittomäki

University of Helsinki
Finland

Medicine

Finland

2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 91 Citations 30,208 283 World Ranking 7324 National Ranking 83

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Finland Leader Award

Overview

What is she best known for?

The fields of study Kristiina Aittomäki is best known for:

Bone morphogenetic protein 15
Pregnancy
Cancer

Her research brings together the fields of Amenorrhea and Genetics. Her work in Amenorrhea is not limited to one particular discipline; it also encompasses Genetics. Internal medicine and Premature ovarian insufficiency are commonly linked in her work. Her research is interdisciplinary, bridging the disciplines of Internal medicine and Premature ovarian insufficiency. She performs multidisciplinary study in the fields of Mutation and Point mutation via her papers. Kristiina Aittomäki performs integrative Point mutation and Mutation research in her work. Her research links Fumarase with Gene. She regularly links together related areas like Gene in her Fumarase studies. Kristiina Aittomäki combines Pregnancy and Live birth in her studies.

Her most cited work include:

Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis (521 citations)
Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure (221 citations)
Increased risk of cancer in patients with fumarate hydratase germline mutation (183 citations)

What are the main themes of her work throughout her whole career to date

Her research on Genetics often connects related topics like Pregnancy. She regularly links together related areas like Genetics in her Pregnancy studies. In her works, she undertakes multidisciplinary study on Gene and Disease. In her works, Kristiina Aittomäki performs multidisciplinary study on Disease and Gene. She incorporates Breast cancer and Cancer research in her studies. She conducted interdisciplinary study in her works that combined Cancer research and Breast cancer. She performs multidisciplinary study in Cancer and Oncology in her work. She merges Oncology with Internal medicine in her study. Her study connects Surgical oncology and Internal medicine.

Kristiina Aittomäki most often published in these fields:

Genetics (80.00%)
Gene (73.33%)
Breast cancer (66.67%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.

Tomlinson Ip;Alam Na;Rowan Aj;Barclay E.
Nature Genetics (2002)

1680 Citations

MUTATION IN THE FOLLICLE-STIMULATING HORMONE RECEPTOR GENE CAUSES HEREDITARY HYPERGONADOTROPIC OVARIAN FAILURE

Kristiina Aittomäki;Kristiina Aittomäki;JoséLuis Dieguez Lucena;JoséLuis Dieguez Lucena;Pirjo Pakarinen;Pertti Sistonen.
Cell (1995)

1123 Citations

RAD51B in Familial Breast Cancer

Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)

1014 Citations

Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Nature (2017)

969 Citations

Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores

Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev.
American Journal of Human Genetics (2015)

960 Citations

Breast-Cancer Risk in Families with Mutations in PALB2

A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale.
The New England Journal of Medicine (2014)

907 Citations

Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis

A Pinborg;U B Wennerholm;L B Romundstad;A Loft.
Human Reproduction Update (2013)

720 Citations

MicroRNA related polymorphisms and breast cancer risk

Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)

629 Citations

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)

616 Citations

Men Homozygous for an Inactivating Mutation of the Follicle-Stimulating Hormone (FSH) Receptor Gene Present Variable Suppression of Spermatogenesis and Fertility

Juha S. Tapanainen;Kristiina Aittomäki;Kristiina Aittomäki;Jiang Min;Tommi Vaskivuo.
Nature Genetics (1997)

611 Citations

If you think any of the details on this page are incorrect, let us know.